Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

@article{Minotti2004AnthracyclinesMA,
  title={Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.},
  author={Giorgio Minotti and Pierantonio Menna and Emanuela Salvatorelli and Gaetano Cairo and Luca Gianni},
  journal={Pharmacological reviews},
  year={2004},
  volume={56 2},
  pages={185-229}
}
The clinical use of anthracyclines like doxorubicin and daunorubicin can be viewed as a sort of double-edged sword. On the one hand, anthracyclines play an undisputed key role in the treatment of many neoplastic diseases; on the other hand, chronic administration of anthracyclines induces cardiomyopathy and congestive heart failure usually refractory to common medications. Second-generation analogs like epirubicin or idarubicin exhibit improvements in their therapeutic index, but the risk of… CONTINUE READING
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS